Search Results
Dec 09, 2025, 10:00 ET Cision utnämner Amy Jones till Chief Marketing Officer
original content:https://www.prnewswire.com/sv/pressmeddelanden/cision-utnamner-amy-jones-till-chief-marketing-officer-302636523.html
More news about: Cision Ltd.
Dec 09, 2025, 07:44 ET Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
DARZALEX FASPRO® U.S. Prescribing Information.6 DARZALEX® U.S. Prescribing Information.7 Rajkumar SV. Multiple Myeloma: 2020 Update on Diagnosis, Risk-Stratification and Management. Am J Hematol. 2020;95(5):548-567.
More news about: Johnson & Johnson
Dec 09, 2025, 01:00 ET Håvors CM öppnar kontor i Köpenhamn för att erbjuda närmare och mer respons stöd till nordiska och europeiska universitet
content:https://www.prnewswire.com/sv/pressmeddelanden/havors-cm-oppnar-kontor-i-kopenhamn-for-att-erbjuda-narmare-och-mer-respons-stod-till-nordiska-och-europeiska-universitet-302634472.html
More news about: AZORUS CRM
Dec 06, 2025, 09:30 ET Earlier use of CARVYKTI® demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma
Society of Clinical Oncology Annual Meeting.4 CARVYKTI® U.S. Prescribing Information. 5 Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95(5):548-5672020;95(5):548-567.
More news about: Johnson & Johnson
Dec 03, 2025, 09:00 ET Mezzion Announces U.S. Patent Allowance Strengthening Udenafil Exclusivity in Fontan Patients
rare disease biopharmaceutical company developing the first treatment specifically for people born with single ventricle congenital heart disease (SV-CHD) who are living with Fontan circulation, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance
More news about: Mezzion Pharmaceuticals, Inc
Dec 02, 2025, 09:00 ET Pegasus Capital Advisors and SDG Digital Transformation Lab Announce New AI Collaborations and a Digital Social Vulnerability Index to Combat Climate Vulnerability
spatial patterns of social vulnerability (SV). DSVI uses machine-learning (ML) techniques, which automate the whole process. Moreover, DSVI uses geographic information systems (GIS) technologies to develop high-resolution maps for improved representation of a country's SV beyond administrative boundaries.The
More news about: Pegasus Capital Advisors
Nov 26, 2025, 03:00 ET Nästan 1 av 3 svenska småföretag planerar inte att använda AI - ny rapport visar att Sverige riskerar digitalt tapp
content:https://www.prnewswire.com/sv/pressmeddelanden/nastan-1-av-3-svenska-smaforetag-planerar-inte-att-anvanda-ai--ny-rapport-visar-att-sverige-riskerar-digitalt-tapp-302626447.html
More news about: team.blue
Nov 25, 2025, 01:00 ET Fisher Investments erkänd som ett "Great Place to Work®"
https://www.fisherinvestments.com/sv-se.Om Fisher InvestmentsFisher Investments är en oberoende, helt avgiftsbaserad investeringsrådgivare. Per 2025-09-30
More news about: Fisher Investments Norden
Nov 20, 2025, 15:33 ET Brandwatch stärker AI-ledarskapet med djupare insikter och utökad datatäckning
content:https://www.prnewswire.com/sv/pressmeddelanden/brandwatch-starker-ai-ledarskapet-med-djupare-insikter-och-utokad-datatackning-302622327.html
More news about: Cision Ltd.
Nov 19, 2025, 04:26 ET Zinzino AB (publ.): Interim Report for the third quarter of 2025
https://www.zinzino.com/site/SE/sv-SE/om-oss/investerare/ For more information, please contact:
More news about: Zinzino
Nov 19, 2025, 04:23 ET Zinzino AB (publ.): Interim Report for the third quarter of 2025
https://www.zinzino.com/site/SE/sv-SE/om-oss/investerare/ For more information, please contact:
More news about: Zinzino
Nov 18, 2025, 06:30 ET Nanopath Granted FDA Breakthrough Device Designation for Its Molecular Diagnostic Platform for Urinary Tract Infections
The Engine built by MIT, a premier facility for high-potential, tough-tech start-ups. Nanopath is backed by Norwest, the Medtech Convergence Fund, a SV Health Investors Fund, Gingerbread Capital and Alumni Ventures. For more information, visit
More news about: Nanopath
Nov 17, 2025, 04:22 ET Vantage nominerat i sju kategorier vid Finance Magnates Awards 2025-galan
content:https://www.prnewswire.com/sv/pressmeddelanden/vantage-nominerat-i-sju-kategorier-vid-finance-magnates-awards-2025-galan-302616879.html
More news about: Vantage
Nov 17, 2025, 03:19 ET Vantage glänser som huvudsponsor på Smart Vision Summit Bahrain 2025 och vinner utmärkelsen "Mest pålitliga mäklare"
content:https://www.prnewswire.com/sv/pressmeddelanden/vantage-glanser-som-huvudsponsor-pa-smart-vision-summit-bahrain-2025-och-vinner-utmarkelsen-mest-palitliga-maklare-302616809.html
More news about: Vantage
Nov 12, 2025, 10:16 ET Träffa Raccoon 2 SE på Kickstarter - AI-driven gräsklippning för små trädgårdar
content:https://www.prnewswire.com/sv/pressmeddelanden/traffa-raccoon-2-se-pa-kickstarter---ai-driven-grasklippning-for-sma-tradgardar-302613213.html
More news about: RoboUp
Nov 12, 2025, 08:00 ET Asembia Announces Charlie Sheen as General Session Speaker for the 2026 Annual Specialty Pharmacy Summit
https://vimeo.com/1126943504?share=copy&fl=sv&fe=ci Media Contact:Bill FitzgeraldVP MarketingAsembiaP:
More news about: Asembia
Nov 11, 2025, 13:21 ET True Global Ventures två stora milstolpar i portföljen inom 72 timmar i USA
content:https://www.prnewswire.com/sv/pressmeddelanden/true-global-ventures-tva-stora-milstolpar-i-portfoljen-inom-72-timmar-i-usa-302611944.html
More news about: True Global Ventures
Nov 11, 2025, 08:37 ET Sailing For Veterans Announces Free Therapeutic Sailing Initiative For Veterans
Sailing For Veterans today announced a new program that honors veterans with free day sails on the sailboat SV INDRA located in Gloucester, MA. Launching on Veterans Day, in partnership with
More news about: Sailing For Veterans
Nov 11, 2025, 06:18 ET Zinzino AB (publ.): Zinzino acquires 35% of the shares in Andorra-based Xion International Group for further development of its own-produced omega-3 oil and spirulina
https://www.zinzino.com/site/se/sv-SE/om-oss/investerare/ For more information, please contact:
More news about: Zinzino
Nov 11, 2025, 06:15 ET Zinzino AB (publ.): Zinzino acquires 35% of the shares in Andorra-based Xion International Group for further development of its own-produced omega-3 oil and spirulina
https://www.zinzino.com/site/se/sv-SE/om-oss/investerare/ For more information, please contact:
More news about: Zinzino
Nov 09, 2025, 20:53 ET Sunseeker Robotics LiDAR Mower S4 utsedd till CES Innovation Awards® 2026 Honoree
content:https://www.prnewswire.com/sv/pressmeddelanden/sunseeker-robotics-lidar-mower-s4-utsedd-till-ces-innovation-awards-2026-honoree-302609622.html
More news about: Sunseeker Robotics
Nov 08, 2025, 10:15 ET AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
Cardiovascular Disease. JACC, Volume 86 (Number 14) Shapiro MD. Circulation. 2022;146(15):1120-1122. Rao SV, O'Donoghue ML, Ruel M, et al. Circulation. 2025;151(13):e771-e862. Vasan, R. S., Enserro, D. M., Xanthakis, V., Beiser, A.
More news about: Amgen
Nov 07, 2025, 09:31 ET Dahua Technology inviger regionalt nav i Budapest och stärker det globala AIoT-ekosystemet och den lokala värdeskapandet
content:https://www.prnewswire.com/sv/pressmeddelanden/dahua-technology-inviger-regionalt-nav-i-budapest-och-starker-det-globala-aiot-ekosystemet-och-den-lokala-vardeskapandet-302608732.html
More news about: Dahua Technology
Nov 06, 2025, 17:07 ET DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma
Primary Results of the AQUILA Study. Presented at the December 2024 ASH Annual Meeting & Exposition. Abstract JJD-78127.7 Rajkumar SV. Multiple Myeloma: 2020 Update on Diagnosis, Risk-Stratification and Management. Am J Hematol. 2020;95(5):548-5672020;95(5):548-567.
More news about: Johnson & Johnson
Nov 06, 2025, 08:04 ET Section Partners Raises $189 Million
venture-backed companies, through both primary and secondary transactions, alongside a dedicated equity co-investment fund, Section Ventures II, LP ("SV II"). The Firm serves as a trusted partner to late-stage, venture-backed companies by providing personal financing solutions to stockholders, purchasing
More news about: Section Partners